# Katakura  Industries  Co.,Ltd.: business model and financials

> Latest period: FY ending Dec 2025, consolidated, J-GAAP
> Unit: JPY millions
> Sources: 有価証券報告書－第117期(2025/01/01－2025/12/31) (S100XTK8)
> Page: https://vizora.meequs.com/en/company/katakura-industries
> Retrieved: 2026-09-30T21:37:49.782Z

## Company

Katakura Industries, founded in 1920, is a company in Textiles & Fibers listed on TSE Standard. It has 900 employees (consolidated).

| Field | Value |
| --- | ---: |
| Legal name | Katakura Industries Co.,Ltd. |
| Ticker | 3001 |
| Stock price | View on Yahoo Finance (https://finance.yahoo.co.jp/quote/3001.T) |
| Listing | TSE Standard |
| Head office | 東京都中央区明石町6番4号 |
| Representative (per filing) | 代表取締役社長 上甲亮祐 |
| Founded | Mar 1920 |
| Share capital | ¥1.82B |
| Employees (consolidated) | 900 |
| Average salary (parent only) | ¥6.9M |
| Fiscal year end | December |
| Website | www.katakura.co.jp (https://www.katakura.co.jp/) |
| Corporate number | 9010001034764 |
| EDINET | E00524 |
| Industries (Vizora) | Textiles & Fibers, Pharmaceuticals, Trucks & Buses, Real Estate Development & Leasing, Disaster Prevention & Infrastructure Maintenance |

> Profile source: annual securities report (S100XTK8, filed 2026-03-26). As of filing

## Five-axis industry profile

Primary industry: Real Estate Development & Leasing (2025-12-31)

| Axis | Industry percentile | Peers |
| --- | ---: | ---: |
| Revenue growth | 11.3 | 75 |
| Profitability | 66.9 | 86 |
| Cash conversion | 73.8 | 82 |
| Efficiency | 21.5 | 86 |

Each axis is shown independently. Missing values are labeled unavailable; no combined score is calculated. Industry rank is not an investment recommendation.

## Key points (generated from figures)

- About 29% of Katakura Industries's sales come from Real estate business, with Pharmaceuticals business and Machinery business making up much of the rest.
- Out of every ¥100 of sales, about ¥14 is left as operating profit.
- Revenue changed +3.1% from the prior year, operating profit +42.0%.

## Company structure

- Segment revenue mix: Real estate business 28.8%、Pharmaceuticals business 28.7%、Machinery business 19.2%、Textiles business 16.8%、Other 6.5%
- Revenue → net income: ¥40652000000 → ¥5815000000
- Net income → operating cash flow: ¥5815000000 → ¥8244000000（difference ¥2429000000）
- Main uses of operating cash flow: CapEx ¥2547000000 / dividends ¥1618000000 / buybacks ¥1444000000
- Change in cash: ¥3172000000
Segment shares use total reported segment revenue, which may include inter-segment sales. The cash bridge is operating cash flow minus net income and combines non-cash items and working-capital effects.

## Key figures at a glance

| Metric | Value | Note |
| --- | ---: | ---: |
| Revenue | ¥40.7B |  |
| Operating income | ¥5.86B | Margin 14.4% |
| Net income | ¥5.76B | Margin 14.2% |
| Free cash flow | ¥5.7B |  |
| Largest business | Real estate business | of segment revenue 28.8% |
| Employees (consolidated) | 900 |  |
| EPS | ¥92.55 |  |
| Book value per share | ¥1154.82 |  |
| Equity ratio | 63.8% |  |
| Shares outstanding | 35,215,000 |  |
| Treasury shares | 3,402,200 |  |
| Shareholders | 13,127 |  |
| Average salary (parent only) | ¥6.9M | Filing company only |
| Cash ratio | 8.1% | Cash ÷ revenue 30.5% |
| Vs. industry median margin | +3.9 pp | Real Estate Development & Leasing |
| ROE | 8.3% | Derived from disclosed figures |
| ROA | 3.9% | Derived from disclosed figures |

## Notable figures

- FY2025, one segment accounts for 64% of positive segment profit
- FY2025, employees -4% while operating income rose 42%
- FY2025, segment profit share differs by 35 points

## What changed in 5 years

| Metric | FY ending Dec 2020 | FY ending Dec 2025 | Change |
| --- | ---: | ---: | ---: |
| Revenue | ¥39639000000 | ¥40652000000 | +2.6% |
| Operating income | ¥3595000000 | ¥5855000000 | +62.9% |
| Operating margin | 9.1% | 14.4% | +5.3 pp |
| Employees | 1,069 people | 900 people | -15.8% |
| Cash and equivalents | ¥8017000000 | ¥12387000000 | +54.5% |

### Change in segment revenue mix

Span: FY ending Dec 2020 → FY ending Dec 2025. Stable segment keys are connected; unmatched shares are marked as new or reorganized. Shares use total segment revenue.

| Flow | Revenue share |
| --- | ---: |
| 不動産 → 不動産 | 24.8% |
| 医薬品 → 医薬品 | 28.7% |
| 医薬品 → 事業再編・廃止 | 5.9% |
| 機械関連 → 機械関連 | 19.2% |
| 機械関連 → 事業再編・廃止 | 1.1% |
| 繊維 → 繊維 | 16.0% |
| その他 → その他 | 4.2% |
| 新設・再編 → 不動産 | 4.0% |
| 新設・再編 → 繊維 | 0.7% |
| 新設・再編 → その他 | 2.3% |

Segment revenue source references: 10 (derived)

## Business growth × margin

X-axis: segment revenue CAGR. Y-axis: latest operating margin. Bubble size: latest revenue. CAGR requires at least two comparable years.

| Segment | CAGR span | Revenue CAGR | Latest revenue | Operating margin | Source refs |
| --- | ---: | ---: | ---: | ---: | ---: |
| Real estate business | 5 years | +3.5% | ¥11699000000 | 37.6% | 2 |
| Pharmaceuticals business | 5 years | -3.2% | ¥11681000000 | 8.2% | 2 |
| Machinery business | 5 years | -0.6% | ¥7819000000 | 9.9% | 2 |
| Textiles business | 5 years | +1.4% | ¥6818000000 | 10.7% | 2 |
| Other | 5 years | +9.7% | ¥2633000000 | 1.9% | 2 |

## Income statement（FY ending Dec 2025, consolidated, J-GAAP）

| Item | Amount (JPY mn) | % of revenue | Source |
| --- | ---: | ---: | ---: |
| Revenue | 40,652 | 100.0% | S100XTK8 |
| Cost of revenue | 26,044 | 64.1% | S100XTK8 |
| Gross profit | 14,607 | 35.9% | S100XTK8 |
| SG&A | 8,752 | 21.5% | S100XTK8 |
| Operating income | 5,855 | 14.4% | S100XTK8 |
| Ordinary income | 7,217 | 17.8% | S100XTK8 |
| Pretax income | 8,608 | 21.2% | S100XTK8 |
| Income tax | 2,793 | 6.9% | S100XTK8 |
| Net income | 5,815 | 14.3% | S100XTK8 |
| Net income attributable to owners | 5,763 | 14.2% | S100XTK8 |

## Per ¥100 of revenue（FY ending Dec 2025）

| Part | JPY |
| --- | ---: |
| Cost of revenue | 64 |
| SG&A | 22 |
| Operating income | 14 |
| (Ref.) Net income | 14 |

### Margin funnel

Gross margin 35.9% → Operating margin 14.4% → Net margin 14.2%
Derived from reported figures (DERIVED).

## Revenue and profit pattern

Pattern: Revenue and profit up
Revenue growth: +3.1%; Core profit growth: +42.0%
Growth quality: margin-expansion
Operating leverage (core profit growth ÷ revenue growth): 13.48×
Calculated from comparable annual consolidated filings.

## Year over year（FY ending Dec 2024 → FY ending Dec 2025、JPY mn）

| Metric | Prior | Current | Change | % change |
| --- | ---: | ---: | ---: | ---: |
| Revenue | 39,424 | 40,652 | 1,228 | +3.1% |
| Gross profit | 14,746 | 14,607 | -139 | -0.9% |
| Operating income | 4,124 | 5,855 | 1,731 | +42.0% |
| Net income attributable to owners | 3,524 | 5,763 | 2,239 | +63.5% |
| Operating cash flow | 5,643 | 8,244 | 2,601 | +46.1% |
| Free cash flow | 3,746 | 5,697 | 1,951 | +52.1% |

## History（JPY mn）

| Period | Revenue | Op. income | Op. margin | Net income | Op. CF | FCF | Source |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| FY ending Dec 2019 | 44,043 | 2,569 | 5.8% | 1,732 | 4,943 | 2,184 | S100L2E6 |
| FY ending Dec 2020 | 39,639 | 3,595 | 9.1% | 2,871 | 6,530 | 5,245 | S100NRNC |
| FY ending Dec 2021 | 37,627 | 2,797 | 7.4% | 4,953 | 4,604 | 3,548 | S100QHC9 |
| FY ending Dec 2022 | 34,274 | 1,369 | 4.0% | 2,817 | -712 | -1,609 | S100T5NY |
| FY ending Dec 2023 | 39,972 | 3,803 | 9.5% | 3,045 | 3,576 | 2,501 | S100VHF8 |
| FY ending Dec 2024 | 39,424 | 4,124 | 10.5% | 3,524 | 5,643 | 3,746 | S100XTK8 |
| FY ending Dec 2025 | 40,652 | 5,855 | 14.4% | 5,763 | 8,244 | 5,697 | S100XTK8 |

## People and productivity（FY ending Dec 2025, consolidated, J-GAAP）

| Metric | Value |
| --- | ---: |
| Revenue per employee (consolidated) | ¥45.2M |
| Operating income per employee (consolidated) | ¥6.5M |
| Net income per employee (consolidated) | ¥6.4M |

Employees, revenue and profit are consolidated. Average annual salary is a separate parent-company figure. Calculated from disclosed figures (DERIVED).

| History | FY ending Dec 2021 | FY ending Dec 2022 | FY ending Dec 2023 | FY ending Dec 2024 | FY ending Dec 2025 |
| --- | ---: | ---: | ---: | ---: | ---: |
| Employees (consolidated) | 1,059 | 1,020 | 1,040 | 941 | 900 |
| Average salary (parent company) | ¥6.1M | ¥6.4M | ¥6.7M | ¥6.7M | ¥6.9M |
| Average age (parent company) | 37.3 years | 39.0 years | 39.1 years | 39.3 years | 40.6 years |
| Average tenure (parent company) | 13.5 years | 14.0 years | 13.9 years | 13.5 years | 11.8 years |

Year over year: Employees (consolidated) -4.4% · Revenue (consolidated) +3.1%

## Segments（FY ending Dec 2025, consolidated, J-GAAP、JPY mn）

| Segment | Revenue | Share | Op. income | Op. margin |
| --- | ---: | ---: | ---: | ---: |
| Real estate business | 11,699 | 28.8% | 4,395 | 37.6% |
| Pharmaceuticals business | 11,681 | 28.7% | 957 | 8.2% |
| Machinery business | 7,819 | 19.2% | 771 | 9.9% |
| Textiles business | 6,818 | 16.8% | 731 | 10.7% |
| Other | 2,633 | 6.5% | 49 | 1.9% |

### segmentMix — Revenue and profit mix

Calculated from disclosed figures (DERIVED). Shares use total segment revenue and total positive segment profit respectively. Difference = profit share − revenue share (pt). Inter-segment sales may prevent reconciliation to company revenue.

| Segment | Revenue share | Profit share | Difference (pt) | Margin |
| --- | ---: | ---: | ---: | ---: |
| Real estate business | 28.8% | 63.7% | 34.9 | 37.6% |
| Pharmaceuticals business | 28.7% | 13.9% | -14.9 | 8.2% |
| Machinery business | 19.2% | 11.2% | -8.1 | 9.9% |
| Textiles business | 16.8% | 10.6% | -6.2 | 10.7% |
| Other | 6.5% | 0.7% | -5.8 | 1.9% |

Segment → industry: Textiles business → Textiles & Fibers / Pharmaceuticals business → Pharmaceuticals / Machinery business → Trucks & Buses / Real estate business → Real Estate Development & Leasing / Machinery business → Disaster Prevention & Infrastructure Maintenance

## Revenue by geography

No geographic revenue breakdown was disclosed.

## Cash flow（FY ending Dec 2025, consolidated, J-GAAP）

| Item | Amount (JPY mn) | % of revenue | Source |
| --- | ---: | ---: | ---: |
| Operating cash flow | 8,244 | 20.3% | S100XTK8 |
| Capital expenditure | 2,547 | 6.3% | S100XTK8 |
| Free cash flow | 5,697 | 14.0% | 算出 |
| Investing cash flow | 609 | 1.5% | S100XTK8 |
| Financing cash flow | -5,681 | -14.0% | S100XTK8 |
| Dividends paid | 1,618 | 4.0% | S100XTK8 |
| Share buyback | 1,444 | 3.6% | S100XTK8 |
| Change in cash | 3,172 | 7.8% | S100XTK8 |
| Cash and equivalents | 12,387 | 30.5% | S100XTK8 |

## Balance sheet

Figures are as of each fiscal year end. Derived values are marked as such in the source column. Lease liabilities are excluded from interest-bearing debt.

| Metric | FY ending Dec 2021 | FY ending Dec 2022 | FY ending Dec 2023 | FY ending Dec 2024 | FY ending Dec 2025 | Source |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | 10,813 | 10,462 | 10,837 | 9,214 | 12,387 | S100T5NY, S100VHF8, S100XTK8 |
| Total assets | 139,973 | 138,114 | 139,611 | 140,786 | 153,049 | S100QHC9, S100T5NY, S100VHF8, S100XTK8 |
| Net assets | 87,611 | 84,475 | 89,365 | 89,731 | 99,761 | S100T5NY, S100VHF8, S100XTK8 |
| Share capital | 1,817 | 1,817 | 1,817 | 1,817 | 1,817 | S100QHC9, S100T5NY, S100VHF8, S100XTK8 |
| Trade receivables | 7,481 | 8,457 | 8,566 | 8,574 | 8,105 | S100QHC9, S100T5NY, S100VHF8, S100XTK8 |
| Property, plant and equipment | 44,789 | 43,171 | 41,573 | 41,162 | 41,420 | S100QHC9, S100T5NY, S100VHF8, S100XTK8 |
| Intangible assets excluding goodwill | 361 | 337 | 632 | 566 | 512 | S100QHC9, S100T5NY, S100VHF8, S100XTK8 |
| Investment securities | 34,151 | 34,408 | 35,657 | 32,887 | 43,321 | S100QHC9, S100T5NY, S100VHF8, S100XTK8 |
| Current assets | 57,059 | 56,379 | 57,151 | 58,437 | 58,526 | S100QHC9, S100T5NY, S100VHF8, S100XTK8 |
| Current liabilities | 18,763 | 19,041 | 17,726 | 20,095 | 19,268 | S100QHC9, S100T5NY, S100VHF8, S100XTK8 |
| Trade payables | 4,377 | 4,823 | 4,279 | 4,785 | 4,702 | S100QHC9, S100T5NY, S100VHF8, S100XTK8 |
| Short-term borrowings | 2,870 | 3,168 | 2,856 | 2,878 | 2,761 | S100QHC9, S100T5NY, S100VHF8, S100XTK8 |
| Long-term borrowings | 6,622 | 8,249 | 5,983 | 4,918 | 2,962 | S100QHC9, S100T5NY, S100VHF8, S100XTK8 |
| Total liabilities | 52,362 | 53,638 | 50,246 | 51,054 | 53,287 | S100QHC9, S100T5NY, S100VHF8, S100XTK8 |
| Non-controlling interests | 25,042 | 14,571 | 14,641 | 3,693 | 2,115 | S100QHC9, S100T5NY, S100VHF8, S100XTK8 |
| Equity attributable to owners of parent | 46,769 | 54,236 | 57,039 | 67,521 | 71,824 | S100QHC9, S100T5NY, S100VHF8, S100XTK8 |
| Retained earnings | 47,095 | 49,247 | 52,160 | 55,166 | 59,307 | S100QHC9, S100T5NY, S100VHF8, S100XTK8 |
| Treasury stock | -2,660 | -2,806 | -3,046 | -4,463 | -5,846 | S100QHC9, S100T5NY, S100VHF8, S100XTK8 |

### Assets and funding mix

| Assets | Share | Source |
| --- | ---: | ---: |
| Cash | 8% | S100XTK8 |
| Receivables | 5% | S100XTK8 |
| Property, plant and equipment | 27% | S100XTK8 |
| Intangibles and goodwill | 1% | S100XTK8 |
| Investment securities | 28% | S100XTK8 |
| Other assets | 31% | S100XTK8 |

| Funding source | Share | Source |
| --- | ---: | ---: |
| Trade payables | 3% | S100XTK8 |
| Other liabilities | 32% | S100XTK8 |
| Equity | 65% | S100XTK8 |
| Other liabilities | 0% | S100XTK8 |

### Balance sheet history

| Metric | FY ending Dec 2021 | FY ending Dec 2022 | FY ending Dec 2023 | FY ending Dec 2024 | FY ending Dec 2025 |
| --- | ---: | ---: | ---: | ---: | ---: |
| Total assets | 139,973 | 138,114 | 139,611 | 140,786 | 153,049 |
| Equity | 87,611 | 84,475 | 89,365 | 89,731 | 99,761 |
| Interest-bearing debt | — | — | — | — | — |
| Cash | 10,813 | 10,462 | 10,837 | 9,214 | 12,387 |

## Asset intensity and goodwill

Ratios are derived from reported values. Goodwill is used only when separately reported, never inferred from combined intangible assets.

| Metric | Value | Sources |
| --- | ---: | ---: |
| Asset intensity (fixed assets ÷ revenue) | 101.9% | S100XTK8 |
| Fixed assets ÷ total assets | 27.1% | S100XTK8 |
| Goodwill ÷ parent equity | — | —, S100XTK8 |

### Cash quality

Net cash = cash − interest-bearing debt. Net debt ratio = (interest-bearing debt − cash) ÷ positive operating cash flow. Omit when debt components are incomplete; other ratios are derived from reported figures.

| Metric | Value |
| --- | ---: |
| Cash ratio (cash ÷ total assets) | 8.1% |
| Cash ÷ revenue | 30.5% |
| Net cash (cash − interest-bearing debt) | — |
| Net debt ÷ operating cash flow | — |
| Cash conversion (operating CF ÷ operating income) | 140.8% |
| Cash vs. profit gap | 2,481 JPY mn (of net income 43.1%) |
| Shareholder returns / net income | 53.1% |
| Shareholder returns / FCF | 53.7% |
| Shareholder payments — dividends / net income | 28.1% |
| Shareholder payments — dividends / FCF | 28.4% |
| CapEx intensity (capex ÷ revenue) | 6.3% |
| Investing CF relative to operating CF | 7.4% |

## ROA and ROE

ROE is decomposed into net margin × asset turnover × financial leverage. Leverage can raise ROE, so the ratio alone does not assess a company's condition. Ending balances are used without a prior year; total equity approximates parent equity when unavailable.

| Period | Net margin | Asset turnover | ROA | Financial leverage | ROE | Sources |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| 2021 | 13.2% | 0.27× | 3.5% | 2.99× | 10.6% | S100QHC9 |
| 2022 | 8.2% | 0.25× | 2.0% | 2.75× | 5.6% | S100T5NY |
| 2023 | 7.6% | 0.29× | 2.2% | 2.50× | 5.5% | S100VHF8 |
| 2024 | 8.9% | 0.28× | 2.5% | 2.25× | 5.7% | S100XTK8 |
| 2025 | 14.2% | 0.28× | 3.9% | 2.11× | 8.3% | S100XTK8 |

## Ownership

| Counterparty | Relation | Ratio | As of |
| --- | ---: | ---: | ---: |
| THE HONGKONG AND SHANGHAI BANKING CORPORATION LTD - SINGAPORE BRANCH PRIVATE BANKING DIVISION A/C CLIENTS（常任代理人 香港上海銀行東京支店） | Major shareholder | 11.2% | 2025-12-31 |
| 三井物産株式会社 | Major shareholder | 6.9% | 2025-12-31 |
| 日本マスタートラスト信託銀行株式会社（信託口） | Major shareholder | 6.1% | 2025-12-31 |
| 損害保険ジャパン株式会社 | Major shareholder | 5.4% | 2025-12-31 |
| 株式会社みずほ銀行 | Major shareholder | 5.0% | 2025-12-31 |
| 安田不動産株式会社 | Major shareholder | 4.1% | 2025-12-31 |
| 農林中央金庫 | Major shareholder | 3.7% | 2025-12-31 |
| CEPLUX- THE INDEPENDENT UCITS PLATFORM ２（常任代理人 シティバンク、エヌ・エイ東京支店） | Major shareholder | 3.7% | 2025-12-31 |
| 大成建設株式会社 | Major shareholder | 3.5% | 2025-12-31 |
| 明治安田生命保険相互会社 | Major shareholder | 3.1% | 2025-12-31 |

## Sources

| Document | ID | Published | URL |
| --- | ---: | ---: | ---: |
| 有価証券報告書－第117期(2025/01/01－2025/12/31) | S100XTK8 | 2026-03-26 | https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100XTK8,, |
| 有価証券報告書－第116期(2024/01/01－2024/12/31) | S100VHF8 | 2025-03-28 | https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100VHF8,, |
| 有価証券報告書－第115期(2023/01/01－2023/12/31) | S100T5NY | 2024-03-28 | https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100T5NY,, |
| 有価証券報告書－第114期(2022/01/01－2022/12/31) | S100QHC9 | 2023-03-30 | https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100QHC9,, |
| 有価証券報告書－第113期(令和3年1月1日－令和3年12月31日) | S100NRNC | 2022-03-30 | https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100NRNC,, |
| 有価証券報告書－第112期(令和2年1月1日－令和2年12月31日) | S100L2E6 | 2021-03-30 | https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100L2E6,, |

## Definitions

- Amounts are in millions of JPY (rounded). The period is stated in each table heading
- Operating margin = operating income ÷ revenue. Net income is attributable to owners of the parent when disclosed
- Free cash flow (FCF) = operating cash flow − capital expenditure
- ¥100 model = breakdown per ¥100 of revenue (rounded so parts sum to 100)
- Segment revenues include inter-segment sales and may not sum to consolidated revenue
- Source IDs are EDINET document IDs (docID). "算出" (derived) means computed from other disclosed values
- All figures are extracted mechanically from filings. AI-written text never generates figures
- Source: company filings submitted to EDINET (Financial Services Agency of Japan). Figures were extracted, edited and processed, and charts and text were created, by Vizora — not by the FSA (used under the Public Data License v1.0).